Randomized Phase II Trial of Anastrozole in Combination With/Without Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Primary Breast Cancer
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Response Rate (confirmed by calipers CT or MRI)
Shinzaburo Noguchi, M.D. , Ph.D.
Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine
Japan: Ministry of Health, Labor and Welfare